GC73391
bPiDI
Also known as 3-methyl-1-[10-(3-methylpyridin-1-ium-1-yl)decyl]pyridin-1-ium diiodide
bPiDI is a novel selective α6β2 nicotinic receptor antagonist· bPiDI inhibits nicotine-evoked striatal dopamine (DA) release through an interaction with α6β2-containing nAChRs
ChemicalCAS525596-64-9MW580.33FormulaC22H34I2N2
- CAS number
- 525596-64-9
- Molecular weight
- 580.33
- Formula
- C22H34I2N2
- Solubility
- DMSO ： 100 mg/mL (172·32 mM; Need ultrasonic)
- InChIKey
- GMIGEVLABVAPDI-UHFFFAOYSA-L
- Catalogue number
- GC73391
- Brand
- GLPBIO
Computed properties PubChem CID 11421854 · TPSA 7.8 Ų · H-bond donors 0 · H-bond acceptors 2
- TPSA
- 7.8 Ų
- H-bond donors
- 0
- H-bond acceptors
- 2
- Rotatable bonds
- 11
- Heavy atoms
- 26
SMILES CC1=C[N+](=CC=C1)CCCCCCCCCC[N+]2=CC=CC(=C2)C.[I-].[I-]
Computed descriptors from PubChem (CID 11421854), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il